BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

Cardiovascular-kidney-metabolic syndrome: integrating metabolism, kidney health, and cardiovascular disease into a unified clinical framework

Authors:Aarushi Batra*, Ashok Kumar
Int J Biol Med Res. 2026; 17(3): 8737-8740  |  PDF File  |  Full Text
DOI No.: 10.65048/ijbmr.2026.17.3.8737.1080

Abstract

Cardiovascular-Kidney-Metabolic (CKM) syndrome reflects the convergence of metabolic dysfunction, chronic kidney disease, and cardiovascular pathology into a unified disease network. Once viewed as parallel comorbidities, these conditions are now recognized as interdependent processes driven by shared mechanisms including insulin resistance, inflammation, neurohormonal activation, oxidative stress, and microvascular dysfunction. This review synthesizes emerging evidence across disciplines to articulate a cohesive framework for CKM syndrome, emphasizing epidemiology, pathophysiology, diagnostic challenges, and therapeutic innovations. We highlight the shift from organ?specific management to integrated, phenotype?driven care and outline future directions in precision medicine and tri?organ clinical trial design. CKM syndrome is rapidly becoming the dominant phenotype in contemporary cardiovascular practice, demanding a unified approach to prevention and treatment.